BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 23909871)

  • 1. Clinical outcome prediction from mean platelet volume in patients undergoing percutaneous coronary intervention in Korean cohort: Implications of more simple and useful test than platelet function testing.
    Choi SW; Choi DH; Kim HW; Ku YH; Ha SI; Park G
    Platelets; 2014; 25(5):322-7. PubMed ID: 23909871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brachial-ankle pulse wave velocity and mean platelet volume as predictive values after percutaneous coronary intervention for long-term clinical outcomes in Korea: A comparable and additive study.
    Seo HJ; Ki YJ; Han MA; Choi DH; Ryu SW
    Platelets; 2015; 26(7):665-71. PubMed ID: 25383727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of mean platelet volume as a biomarker for long-term clinical outcomes after percutaneous coronary intervention in Korean cohort: a comparable and additive predictive value to high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide.
    Ki YJ; Park S; Ha SI; Choi DH; Song H
    Platelets; 2014; 25(6):427-32. PubMed ID: 24102424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitivity C-reactive protein and mean platelet volume as predictive values after percutaneous coronary intervention for long-term clinical outcomes: a comparable and additive study.
    Moon AR; Choi DH; Jahng SY; Kim BB; Seo HJ; Kim SH; Ryu SW; Song H; Kim TH
    Blood Coagul Fibrinolysis; 2016 Jan; 27(1):70-6. PubMed ID: 26340462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between the Change in Mean Platelet Volume and Clopidogrel Resistance in Patients Undergoing Percutaneous Coronary Intervention.
    Koh YY; Kim HH; Choi DH; Lee YM; Ki YJ; Kang SH; Park G; Chung JW; Chang KS; Hong SP
    Curr Vasc Pharmacol; 2015; 13(5):687-93. PubMed ID: 25322834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of platelet indices after acute myocardial infarction treated with primary percutaneous coronary intervention.
    Rechciński T; Jasińska A; Foryś J; Krzemińska-Pakuła M; Wierzbowska-Drabik K; Plewka M; Peruga JZ; Kasprzak JD
    Cardiol J; 2013; 20(5):491-8. PubMed ID: 24469872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of P2Y12 reaction unit and percentage of platelet inhibition assessed by VerifyNow P2Y12 assay is a useful predictor of long-term clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Luo Y; Li J; Liu X; Xu J; Ye Z; Yao Y; Liu X; Lai Y
    Thromb Res; 2016 Mar; 139():114-20. PubMed ID: 26916306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of Mean Platelet Volume and Neutrophil to Lymphocyte Ratio Predicts Long-Term Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention.
    Choi DH; Kobayashi Y; Nishi T; Kim HK; Ki YJ; Kim SS; Park KH; Song H; Fearon WF
    Angiology; 2019 Apr; 70(4):345-351. PubMed ID: 29631419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
    Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
    Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of mean platelet volume on prognosis of patients with and without aspirin resistance in settings of non-ST-segment elevated acute coronary syndromes.
    Aksu H; Ozer O; Unal H; Hobikoglu G; Norgaz T; Buturak A; Soylu O; Narin A
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):686-93. PubMed ID: 19730245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial changes of mean platelet volume in relation to Killip Class in patients with acute myocardial infarction and primary percutaneous coronary intervention.
    Wang XY; Yu HY; Zhang YY; Wang YP; Feng XH; Li ZP; Du XJ; Gao W
    Thromb Res; 2015 Apr; 135(4):652-8. PubMed ID: 25682433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
    EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of mean platelet volume on short- and long-term outcomes among patients with non-ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: A single-center large observational study.
    Wasilewski J; Desperak P; Hawranek M; Ciślak A; Osadnik T; Pyka Ł; Gawlita M; Bujak K; Niedziela J; Krawczyk M; Gąsior M
    Platelets; 2016 Jul; 27(5):452-8. PubMed ID: 26939525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome.
    Taglieri N; Saia F; Rapezzi C; Marrozzini C; Bacchi Reggiani ML; Palmerini T; Ortolani P; Melandri G; Rosmini S; Cinti L; Alessi L; Vagnarelli F; Villani C; Branzi A; Marzocchi A
    Thromb Haemost; 2011 Jul; 106(1):132-40. PubMed ID: 21614413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke prediction using mean platelet volume in patients with atrial fibrillation.
    Ha SI; Choi DH; Ki YJ; Yang JS; Park G; Chung JW; Koh YY; Chang KS; Hong SP
    Platelets; 2011; 22(6):408-14. PubMed ID: 21599611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
    Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
    Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mean platelet volume as a predictor for long-term outcome after percutaneous coronary intervention.
    Eisen A; Bental T; Assali A; Kornowski R; Lev EI
    J Thromb Thrombolysis; 2013 Nov; 36(4):469-74. PubMed ID: 23345043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of platelet turnover on long-term adverse cardiovascular outcomes in patients undergoing percutaneous coronary intervention.
    Tscharre M; Farhan S; Bruno V; Rohla M; Egger F; Weiss TW; Hübl W; Willheim M; Wojta J; Geppert A; Huber K; Freynhofer MK
    Eur J Clin Invest; 2019 Sep; 49(9):e13157. PubMed ID: 31318979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of mean platelet volume to platelet count ratio in older patients with non-ST elevation acute coronary syndrome receiving primary percutaneous coronary intervention: a retrospective study.
    Sun X; Li H; Zhang Y; He F; Lu C
    Minerva Cardioangiol; 2019 Apr; 67(2):102-108. PubMed ID: 30621371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing P2Y12 receptor inhibition in patients with acute coronary syndrome on the basis of platelet function testing: impact of prasugrel and high-dose clopidogrel.
    Aradi D; Tornyos A; Pintér T; Vorobcsuk A; Kónyi A; Faluközy J; Veress G; Magyari B; Horváth IG; Komócsi A
    J Am Coll Cardiol; 2014 Mar; 63(11):1061-70. PubMed ID: 24486281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.